search

Active clinical trials for "Bone Diseases, Metabolic"

Results 271-280 of 355

Classic Yin and Yang Tonic Formula for Osteopenia

Osteopenia

The purpose of this study is to evaluate the efficacy and safety of the classic yin and yang tonic formula for osteopenia and to research the mechanism of efficacy.

Unknown status14 enrollment criteria

Proton Pump Inhibitor Therapy and Bone Density in Premature Infants

OsteopeniaPrematurity

Previous research studies have shown that there may be a connection between proton pump inhibitor therapies and hip fracture in adults(1). Proton pump inhibitor(PPI) reflux medications raise the pH of the stomach, which may effect the body's ability to absorb certain calcium compounds. Neonates are at a crucial age for bone mineralization. Because esophageal reflux is common in neonates, PPI therapy is commonly used, despite little information on effectiveness and side effects. PPIs work by blocking the production of protons in the pumps in the stomach, thus making the stomach less acidic. The calcium ion needs an acidic environment in order to be broken down from its natural compounds into an absorbable form (2). This is troubling because of the problems associated with osteopenia in neonates. Bone mineralization is important for premature infants. Rickets and bone fractures are higher in preterm infants than term infants. For this reason, we are investigating whether there is a connection between PPI therapies (specifically Prevacid) and decreased bone densities in neonates. The objective is to determine if a connection exists between proton pump inhibitor antacids and decreased rate of bone mineralization in neonates.

Terminated2 enrollment criteria

Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation,...

OsteoporosisOsteopenia

This study is being conducted to evaluate the effect treatment has on serum P1NP levels, a biomarker of bone formation in postmenopausal women with low bone mass.

Unknown status9 enrollment criteria

Translational Development of Photon-counting CT Imaging

CancerInflammatory Disease2 more

Using an investigational CT scanner which uses a new type of detector to capture X-rays, (a photon counting CT detector), the goal of this experimental study is to compare conventional CT images to CT images using the photon counting detector in patients undergoing CT scans for clinically indicated reasons. The main question it aims to answer is whether the images produced using the new detectors are superior in quality. Participants will undergo the clinically indicated CT images and the photon counting detector CT images of a limited area during the same examination time.

Completed11 enrollment criteria

Comparison of Two Different Doses of Vitamin D in Preterm Infants

Osteopenia of Prematurity

randomized clinical trial comparing two different doses of vitamin d supplementation in preterm infants

Unknown status5 enrollment criteria

Prevention of Post Operative Bone Loss in Children

OsteoporosisCerebral Palsy3 more

Hypothesis: one-dose pamidronate will prevent post-operative bone loss in children at risk for low bone density Plan: children with chronic disease such as CP, spina bifida, etc. will be recruited pre operatively and studied with DXA scan. After surgery, children will be randomized to receive either pamidronate or saline. Repeat DXA scan will determine bone lost after end of immobilization or nonweightbearing.

Completed6 enrollment criteria

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

Breast CancerOsteoporosis2 more

Research Question: Do Aromatase Inhibitors Decrease Intestinal Calcium Absorption? Study Design: Postmenopausal women with early stage breast cancer initiating aromatase inhibitor adjuvant therapy will participate in this two-month study. The primary study outcome is the change in intestinal calcium absorption following such therapy. Secondary outcomes are the changes in bone resorption markers and musculoskeletal signs and symptoms after initiation of therapy. We will interview women and review their medical records to determine eligibility. Eligible subjects will undergo two calcium absorption studies. The first study will determine their baseline calcium absorption, and the second study will occur after taking an aromatase inhibitor daily for at least 6 weeks. Women will present to the research unit in the early morning and receive an oral and intravenous stable calcium tracer with breakfast. Over the next 24 hours, we will collect all urine for measurement of its calcium content. During each inpatient stay, we will assess musculoskeletal symptoms by questionnaire and joint examination. Each woman will complete a four-day diet diary twice during the study.

Completed9 enrollment criteria

"VIBES"--Low Magnitude Mechanical Stimulation to Improve Bone Mineral Density

Osteopenia

The purpose of this study is to determine if daily low magnitude, high frequency whole body vibration can improve bone density in seniors.

Completed12 enrollment criteria

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a...

Osteopenia

The primary purpose of the protocol is to evaluate the sensitivity of 3D-pQCT (3D-Peripheral Quantitative Computed Tomography) technology to detect minute changes in bone microarchitecture.

Completed8 enrollment criteria

Evaluation of Marginal Bone Loss Using Computer Guided Ridge Splitting Technique With Simultaneous...

Marginal Bone LossComputer Guided1 more

This clinical report describes a technique for ridge splitting, and gradual expansion in the maxilla with simultaneous implant placement with in the split ridge, with the preservation of the thin buccal plate of bone for proper blood supply.

Unknown status22 enrollment criteria
1...272829...36

Need Help? Contact our team!


We'll reach out to this number within 24 hrs